Follow
Dr. Georgios Deraos
Dr. Georgios Deraos
Verified email at upatras.gr
Title
Cited by
Cited by
Year
Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease
M Ioannou, T Alissafi, I Lazaridis, G Deraos, J Matsoukas, A Gravanis, ...
The Journal of Immunology 188 (3), 1136-1146, 2012
2622012
Round and round we go: cyclic peptides in disease
M Katsara, T Tselios, S Deraos, G Deraos, MT Matsoukas, E Lazoura, ...
Current medicinal chemistry 13 (19), 2221-2232, 2006
1922006
Design of Novel Cyclic Altered Peptide Ligands of Myelin Basic Protein MBP83−99 That Modulate Immune Responses in SJL/J Mice
M Katsara, G Deraos, T Tselios, J Matsoukas, V Apostolopoulos
Journal of medicinal chemistry 51 (13), 3971-3978, 2008
612008
Recognition pliability is coupled to structural heterogeneity: a calmodulin intrinsically disordered binding region complex
M Nagulapalli, G Parigi, J Yuan, J Gsponer, G Deraos, VV Bamm, ...
Structure 20 (3), 522-533, 2012
592012
Citrullination of Linear and Cyclic Altered Peptide Ligands from Myelin Basic Protein (MBP87−99) Epitope Elicits a Th1 Polarized Response by T Cells Isolated …
G Deraos, K Chatzantoni, MT Matsoukas, T Tselios, S Deraos, M Katsara, ...
Journal of medicinal chemistry 51 (24), 7834-7842, 2008
582008
Altered peptide ligands of myelin basic protein (MBP87–99) conjugated to reduced mannan modulate immune responses in mice
M Katsara, E Yuriev, PA Ramsland, T Tselios, G Deraos, A Lourbopoulos, ...
Immunology 128 (4), 521-533, 2009
532009
Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding
K Gkountelias, T Tselios, M Venihaki, G Deraos, I Lazaridis, O Rassouli, ...
Molecular pharmacology 75 (4), 793-800, 2009
522009
Design and Synthesis of a Cyclic Double Mutant Peptide (cyclo(87−99)[A91,A96]MBP87−99) Induces Altered Responses in Mice after Conjugation to Mannan …
M Katsara, G Deraos, T Tselios, MT Matsoukas, I Friligou, J Matsoukas, ...
Journal of medicinal chemistry 52 (1), 214-218, 2009
432009
Towards immunotherapeutic drugs and vaccines against multiple sclerosis
M Katsara, J Matsoukas, G Deraos, V Apostolopoulos
Acta biochimica et biophysica Sinica 40 (7), 636-642, 2008
422008
A double mutation of MBP83–99 peptide induces IL-4 responses and antagonizes IFN-γ responses
M Katsara, E Yuriev, PA Ramsland, G Deraos, T Tselios, J Matsoukas, ...
Journal of neuroimmunology 200 (1-2), 77-89, 2008
412008
Mannosylation of mutated MBP83–99 peptides diverts immune responses from Th1 to Th2
M Katsara, E Yuriev, PA Ramsland, G Deraos, T Tselios, J Matsoukas, ...
Molecular immunology 45 (13), 3661-3670, 2008
402008
Regulatory cell populations in relapsing-remitting multiple sclerosis (RRMS) patients: effect of disease activity and treatment regimens
M Rodi, N Dimisianos, AL De Lastic, P Sakellaraki, G Deraos, ...
International Journal of Molecular Sciences 17 (9), 1398, 2016
292016
Properties of myelin altered peptide ligand cyclo (87-99)(Ala91, Ala96) MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis
G Deraos, M Rodi, H Kalbacher, K Chatzantoni, F Karagiannis, ...
European journal of medicinal chemistry 101, 13-23, 2015
232015
Comparison of proposed putative active conformations of myelin basic protein epitope 87− 99 linear altered peptide ligands by spectroscopic and modelling studies: the role of …
ED Mantzourani, TV Tselios, SG Grdadolnik, JA Platts, A Brancale, ...
Journal of medicinal chemistry 49 (23), 6683-6691, 2006
222006
Cyclic MOG35–55 ameliorates clinical and neuropathological features of experimental autoimmune encephalomyelitis
A Lourbopoulos, G Deraos, MT Matsoukas, O Touloumi, ...
Bioorganic & medicinal chemistry 25 (15), 4163-4174, 2017
162017
Cyclic citrullinated mbp87–99 peptide stimulates t cell responses: Implications in triggering disease
V Apostolopoulos, G Deraos, MT Matsoukas, S Day, L Stojanovska, ...
Bioorganic & medicinal chemistry 25 (2), 528-538, 2017
112017
Comparison of proposed putative active conformations of linear altered peptide ligands of myelin basic protein epitope 87–99 by spectroscopic and modelling studies: the role of …
ED Mantzourani, TV Tselios, SG Grdadolnik, JA Platts, A Brancale, ...
J. Med. Chem 49 (23), 6683-6691, 2006
102006
Cyclization of PLP139-151 peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitis
A Lourbopoulos, MT Matsoukas, M Katsara, G Deraos, A Giannakopoulou, ...
Bioorganic & Medicinal Chemistry 26 (9), 2221-2228, 2018
92018
Design of Linear and Cyclic Mutant Analogues of Dirucotide Peptide (MBP82–98) against Multiple Sclerosis: Conformational and Binding Studies to MHC Class II
G Deraos, E Kritsi, MT Matsoukas, K Christopoulou, H Kalbacher, ...
Brain Sciences 8 (12), 213, 2018
72018
Myelin peptide–mannan conjugate multiple sclerosis vaccines: conjugation efficacy and stability of vaccine ingredient
J Matsoukas, G Deraos, K Kelaidonis, MK Hossain, J Feehan, AG Tzakos, ...
Vaccines 9 (12), 1456, 2021
62021
The system can't perform the operation now. Try again later.
Articles 1–20